The FDA said it is hiring more than 1,000 new staffers and piloting an email 'quick clarification' program to speed sponsor interactions and reduce review uncertainty. Commissioner Marty Makary framed the move as a way to give sponsors prompt feedback after meetings, with staff expected to reply within three business days. Separately, internal concerns surfaced after an agency vote reportedly excluded the drug review team from a decision tied to the Commissioner’s National Priority Voucher, raising questions about review governance and potential politicization.